Acute coronary syndromes
KEYWORDS: people, coronary, acute, pci, risk, acute coronary, therapy, recommendations, committee, evidence, angina, unstable, nstemi, unstable angina, offer

an alternative treatment. [2007] 1.4.18 People with a history of dyspepsia should be considered for treatment in line with the NICE guideline on gastro-oesophageal reflux disease and dyspepsia in adults. [2007, amended 2013] 1.4.19 After appropriate treatment, people with a history of aspirin-induced ulcer bleeding whose ulcers have healed and who are negative for Helicobacter pylori should be considered for treatment in line with the NICE guideline on gastro- oesophageal reflux disease and dyspepsia in adults. [2007, amended 2013] Acute coronary syndromes (NG185) 1.4.20 Offer clopidogrel instead of aspirin to people who also have other clinical vascular disease, and who have: • had an MI and stopped dual antiplatelet therapy or • had an MI more than 12 months ago. [2013] Clopidogrel is recommended as an option in NICE technology appraisal guidance to prevent occlusive vascular events in some people. For full details, see the guidance on clopidogrel (TA210, 2010). Antiplatelet therapy for people with an ongoing separate indication for anticoagulation 1.4.21 For people who have a separate indication for anticoagulation, take into account all of the following when thinking about the duration and type (dual or single) of antiplatelet therapy in the 12 months after an acute coronary syndrome:
